Whitening efficacy of plant extracts including orchid extracts on Japanese female skin with melasma and lentigo senilis
Taketsugu TADOKORO
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorJean C. ARCHAMBAULT
LVMH Recherche, Saint Jean de Braye, France
Search for more papers by this authorKentaro OZAWA
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorFumihito NOGUCHI
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorAya IKEDA
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorMaki NAGAMATSU
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorSachiko SHINN
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorTaketsugu TADOKORO
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorJean C. ARCHAMBAULT
LVMH Recherche, Saint Jean de Braye, France
Search for more papers by this authorKentaro OZAWA
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorFumihito NOGUCHI
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorAya IKEDA
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorMaki NAGAMATSU
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorSachiko SHINN
Department of Dermatology, Osaka National Hospital, National Hospital Organization, Osaka, Japan
Search for more papers by this authorAbstract
The purpose of this study was to assess the in vivo efficacy of a cosmetic formulation containing plant extracts including orchid extracts, compared to 3% vitamin C derivative formulated with the same excipient, in Japanese female adult volunteers with melasma and/or lentigo senilis. The ethics committee of Osaka National Hospital approved the protocol of the study. Before recruitment, selection and inclusion of a volunteer in this study, signed informed consent was obtained from each volunteer after she was given clear and precise information on the study, enabling her to appreciate the aim of the study and the consequences of her consent. Forty-eight female volunteers aged 30–60 years applied the plant extracts and vitamin C derivative to one side of the face. After repeated application for 8 weeks, efficacy was evaluated clinically by colorimetric measurements and subjectively using a questionnaire. After 8 weeks of treatment, both the clinical evaluations by a dermatologist and the questionnaire surveys by volunteers indicated that the cosmetic formulation containing plant extracts was significantly effective in improving the size, brightness, color intensity, clarity, visibility and global appearance of the pigmented spots, and also the luminosity complexion and skin clarity of the face. The good agreement between the results of clinical evaluations and those of questionnaire surveys showed that the orchid-rich plant extracts possess efficacy similar to vitamin C derivative in whitening the skin as well as melasma and lentigo senilis on the face of Japanese women.
References
- 1 Saito T, Miyagaki N, Sigai T, Aoki K, Hamada T, Sakurane T. Statistical observation about facial pigment disorders in our department. Hifu 1966; 8: 169–171 (In Japanese.).
- 2
Kobori T,
Ikemura I.
Senile pigment freckle –special reference to histological features.
Nishinihon J Dermatol
1972; 34: 545–552
(In Japanese.).
10.2336/nishinihonhifu.34.545 Google Scholar
- 3 Sanchez NP, Pathak MA, Sato S, Fitzpatrick TB, Sanchez JL, Mihm MC Jr. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698–710.
- 4 Kadono S, Manaka I, Kawashima M, Kobayashi T, Imokawa G. The role of the epidermal endothelin cascade in the hyperpigmentation mechanism of lentigo senilis. J Invest Dermatol 2001; 116: 571–577.
- 5 Arndt KA, Fitzpatrick TB. Topical use of hydroquinone as a depigmenting agent. JAMA 1965; 194: 965–967.
- 6 Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa D Jr. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol 2003; 42: 153–156.
- 7 Draelos ZD. The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups. J Cosmet Dermatol 2006; 5: 239–244.
- 8 Sugai T. Clinical effects of arbutin in patients with chloasma. Hifu 1992; 34: 552–529. (In Japanese.).
- 9 Maeda K, Fukuda M. Arbutin: mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther 1996; 276: 765–769.
- 10 Baliña LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 1991; 30: 893–895.
- 11 Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 1993; 129: 415–421.
- 12 Mishima Y, Ohyama Y. Inhibitory action of kojic acid on melanogenesis and its therapeutic effect for various human hyper-pigmentation disorders. Hifu 1994; 36: 134–150. (In Japanese.)
- 13 Kondou S, Okada Y, Tomita Y. Clinical study of effect of tranexamic acid emulsion on melasma and freckles. Skin Research 2007; 6: 309–315. (In Japanese.)
- 14
Researching Committee of Rucinol®.
The study on the efficacy of Rucinol® (4-n-butylresorcinol) in chloasma.
Nishinihon J Dermatol
1999; 61: 813–819. (In Japanese.)
10.2336/nishinihonhifu.61.813 Google Scholar
- 15 Stiller MJ, Bartolone J, Stern R et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Arch Dermatol 1996; 132: 631–636.
- 16 Hakozaki T, Minwalla L, Zhuang J et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 2002; 147: 20–31.
- 17 Tomita Y, Hariu A, Mizuno C, Seiji M. Inactivation of tyrosinase by dopa. J Invest Dermatol 1980; 75: 379–382.
- 18 Kameyama K, Sakai C, Kondoh S et al. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol 1996; 34: 29–33.
- 19 Humbert PG, Haftek M, Creidi P et al. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Exp Dermatol 2003; 12: 237–244.
- 20 Farris PK. Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions. Dermatol Surg 2005; 31: 814–817.
- 21 Elmore AR. Final report of the safety assessment of L-ascorbic acid, calcium ascorbate, magnesium ascorbate, magnesium ascorbyl phosphate, sodium ascorbate, and sodium ascorbyl phosphate as used in cosmetics. Int J Toxicol 2005; 24: 51–111.
- 22 Kong JM, Goh NK, Chia LS, Chia TF. Recent advances in traditional plant drugs and orchids. Acta Pharmacol Sin 2003; 24: 7–21.
- 23 Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 1998; 11: 355–361.
- 24 Shimogaki H, Tanaka Y, Tamai H, Masuda M. In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition. Int J Cosmet Sci 2000; 22: 291–303.
- 25 Ando H, Watabe H, Valencia JC et al. Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function. J Biol Chem 2004; 279: 15427–15433.
- 26 Imokawa G, Kobayashi T, Miyagishi M, Higashi K, Yada Y. The role of endothelin-1 in epidermal hyperpigmentation and signaling mechanisms of mitogenesis and melanogenesis. Pigment Cell Res 1997; 10: 218–228.
- 27 Konishi N, Kawada A, Morimoto Y et al. New approach to the evaluation of skin color of pigmentary lesions using Skin Tone Color Scale. J Dermatol 2007; 34: 441–446.
- 28 Ros JR, Rodríguez-López JN, García-Cánovas F. Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. Biochem J 1993; 295: 309–312.
- 29 Jiménez-Cervantes C, Solano F, Kobayashi T et al. A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J Biol Chem 1994; 269: 17993–8000.
- 30 Zhu W, Gao J. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. J Investig Dermatol Symp Proc 2008; 13: 20–24.
- 31 Lin WS, Chan WC, Hew CS. Superoxide and traditional Chinese medicines. J Ethnopharmacol 1995; 48: 165–171.
- 32 Johnson MK, Alexander KE, Lindquist N, Loo G. A phenolic antioxidant from the freshwater orchid, Habenaria repens. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1999; 122: 211–214.
- 33 Tadokoro T, Kobayashi N, Zmudzka BZ et al. UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin. FASEB J 2003; 17: 1177–1179.
- 34 Franchi J, Coutadeur MC, Marteau C, Mersel M, Kupferberg A. Depigmenting effects of calcium D-pantetheine-S-sulfonate on human melanocytes. Pigment Cell Res 2000; 13: 165–171.
- 35 Burgess C. Topical vitamins. J Drugs Dermatol 2008; 7: s2–6.
- 36 Furukawa F, Kanehara S, Harano F et al. Effects of adenosine 5′-monophosphate on epidermal turnover. Arch Dermatol Res 2008; 300: 485–493.